Hsin‐I Chang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 6
- Electrospun Nanofibers in Biomedical Applications 5
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Ming−Yen Cheng (2 shared papers)Ming‐Kung Yeh (1 shared paper)Cheng‐Nan Chen (15 shared papers)Allan G.A. Coombes (4 shared papers)Yiwei Wang (6 shared papers)A.G.A. Coombes (3 shared papers)Shun‐Fu Chang (8 shared papers)Mong Liang (1 shared paper)
- Journals
- Journal of Cellular Physiology (4 papers)Biomaterials (3 papers)Journal of Cellular Biochemistry (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Basic and Clinical Physiology and Pharmacology (2 papers)
- Partner nations
- TaiwanAustraliaUnited Kingdom
In The Last Decade
Hsin‐I Chang
47 papers receiving 1.5k citations
Hsin‐I Chang's Hit Papers
Peers
Comparison fields: 5 of 122
- Biomaterials 578
- Pharmaceutical Science 170
- Rehabilitation 67
- Molecular Medicine 47
- Biomedical Engineering 363
Countries citing papers authored by Hsin‐I Chang
This map shows the geographic impact of Hsin‐I Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐I Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐I Chang more than expected).
Fields of papers citing papers by Hsin‐I Chang
This network shows the impact of papers produced by Hsin‐I Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐I Chang. The network helps show where Hsin‐I Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsin‐I Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy Hit paper breakdown → | 2011 | 655 |
| 2 | 2010 | 52 | |
| 3 | 2007 | 46 | |
| 4 | 2017 | 46 | |
| 5 | 2007 | 38 | |
| 6 | 2010 | 36 | |
| 7 | 2011 | 34 | |
| 8 | 2021 | 34 | |
| 9 | 2004 | 29 | |
| 10 | 2005 | 28 | |
| 11 | 2009 | 27 | |
| 12 | 2019 | 27 | |
| 13 | 2012 | 24 | |
| 14 | 2010 | 23 | |
| 15 | 2018 | 22 | |
| 16 | 2018 | 21 | |
| 17 | 2013 | 21 | |
| 18 | 2009 | 21 | |
| 19 | 2018 | 20 | |
| 20 | 2017 | 18 |
About Hsin‐I Chang
Hsin‐I Chang is a scholar working on Biomaterials, Molecular Biology, Pharmaceutical Science, Rheumatology and Biomedical Engineering, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Advanced Drug Delivery Systems (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Bone Tissue Engineering Materials (5 papers), Cell Adhesion Molecules Research (4 papers), RNA Interference and Gene Delivery (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). The work is most often cited by research in Biomaterials (578 citations), Pharmaceutical Science (170 citations), Rehabilitation (67 citations), Molecular Medicine (47 citations) and Biomedical Engineering (363 citations). Hsin‐I Chang has collaborated with scholars based in Taiwan, Australia and United Kingdom. Frequent co-authors include Ming−Yen Cheng, Ming‐Kung Yeh, Cheng‐Nan Chen, Allan G.A. Coombes, Yiwei Wang, A.G.A. Coombes, Shun‐Fu Chang, Mong Liang, Kuo‐Yuan Huang and Ko‐Chao Lee. Their work appears in journals such as Journal of Cellular Physiology, Biomaterials, Journal of Cellular Biochemistry, International Journal of Molecular Sciences and Journal of Basic and Clinical Physiology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.